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ABSTRACT
Astrocytes possess GPCRs (G-protein-coupled receptors) for
neuroactive substances and can respond via these
receptors to signals originating from neurons as well as
astrocytes. Like many transmembrane proteins, GPCRs exist
in a dynamic equilibrium between receptors expressed at
the plasma membrane and those present within intracel-
lular trafficking compartments. The characteristics of GPCR
trafficking within astrocytes have not been investigated.
We therefore monitored the trafficking of recombinant
fluorescent protein chimeras of the CB1R (cannabinoid
receptor 1) that is thought to be expressed natively in
astrocytes. CB1R chimeras displayed a marked punctate
intracellular localization when expressed in cultured rat
visual cortex astrocytes, an expression pattern reminiscent
of native CB1R expression in these cells. Based upon
trafficking characteristics, we found the existence of two
populations of vesicular CB1R puncta: (i) relatively
immobile puncta with movement characteristic of diffusion
and (ii) mobile puncta with movement characteristic of
active transport along cytoskeletal elements. The predom-
inant direction of active transport is oriented radially to/
from the nuclear region, which can be abolished by
disruption of the microtubule cytoskeleton. CB1R puncta
are localized within intracellular acidic organelles, mainly
co-localizing with endocytic compartments. Constitutive
trafficking of CB1R to and from the plasma membrane is
an energetically costly endeavour whose function is at
present unclear in astrocytes. However, given that
intracellular CB1Rs can engage cell signalling pathways,
it is likely that this process plays an important regulatory
role.
Key words: actin, acutely isolated astrocyte, cannabinoid
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INTRODUCTION
Astrocytes are a diverse population of glial cells, with
functions ranging from structural support to modulation of
synaptic transmission. Astrocytes possess a multitude of
receptors [reviewed in (Verkhratsky, 2006)] for signalling
molecules released by neurons and themselves, including the
cannabinoid receptor 1, CB1R (Rodriguez et al., 2001), which
is thought to mediate neuron–astrocyte communication
(Navarrete and Araque, 2008). Protein trafficking plays an
important role in regulating CB1R expression, with receptors
changing localization between the plasma membrane and
intracellular compartments. In certain cell types at rest, CB1R
is constitutively endocytosed, leading to a predominantly
intracellular localization (Leterrier et al., 2004; McDonald et
al., 2007a). Thus endocytic trafficking can be an important
regulator of CB1R availability at the plasma membrane.
Few studies on protein trafficking have been carried out in
astrocytes. These have been limited to studies of the secreted
ANP (atrial natriueticpeptide),the serpin PN-1 (protease nexin-
1) and the synaptic-vesicle-associated protein synaptobrevin
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Potokar et al., 2007). As these molecules all function within the
exocytotic pathway, they are likely to have similar trafficking
dynamics and may be found within common vesicle pools. As
the picture of how proteins found within the exocytotic
pathway traffic in astrocytes is being elucidated, there are no
comparative data as to the trafficking of receptors, such as
GPCRs (G-protein-coupled receptors), in astrocytes. The
trafficking of GPCRs, such as CB1R and the b-2 adrenergic
receptor, which are expressed by astrocytes (Aoki et al., 1987;
Rodriguez et al., 2001), is better understood in other cell types,
particularly with regard to endocytic trafficking (Coutts et al.,
2001; Leterrier et al., 2004; Shumay et al., 2004).
In the present study, we have investigated CB1R expression
and intracellular trafficking within cultured astrocytes
isolated from rat visual cortex. Fluorescent CB1R chimeras
were used in combination with pharmacological agents to
examine CB1R trafficking dynamics. Our findings indicate
that within cultured astrocytes at rest there is a pronounced
vesicular pool of CB1Rs, which is trafficked both by
microtubule- and actin-based mechanisms; microtubule-
dependent radial shuttling towards and away from the cell
centre is evident. In addition, a population of CB1R–GFP
(green fluorescent protein) was found to be relatively
immobile, with movement characteristic of passive diffusion.
Astrocytes expressing a SEP (superecliptic pHluorin)-tagged
CB1R (SEP–CB1R) and treated with bafilomycin A1 showed
the presence of CB1R within low-pH endocytic intracellular
compartments. We found that the punctate CB1R–GFP label
mainly co-localized with the endosomal marker endobrevin
[also referred to as VAMP8 (vesicle-associated membrane
protein 8)].
Trafficking of receptors to and from the astrocyte plasma
membrane probably shapes astrocytic responses to signalling
molecules, but the nature of receptor trafficking in astrocytes
has yet to be investigated in detail. To our knowledge the
present study of CB1R trafficking constitutes the first
investigation of receptor protein trafficking in astrocytes.
This should be of additional importance when one considers
the previous demonstration of preferential localization of
CB1R in situ to the astrocytic end-foot (Rodriguez et al.,
2001). Future studies of CB1R trafficking in more intact
systems may help to develop our understanding of how
membrane proteins are preferentially localized to distinct
domains of astrocytes and how they influence local cell
signalling.
MATERIALS AND METHODS
Cell culture
All animal procedures were in strict accordance with the
National Institutes of Health Guide for Care and Use of
Laboratory Animals and were approved by the University of
Alabama at Birmingham Institutional Animal Care and Use
Committee.
Visual cortices were dissected from 0–2-day-old Sprague–
Dawley rats and treated with papain (20 i.u./ml; Sigma) in
HBSS (Hanks balanced salt solution; Invitrogen) for 1 h at
37˚C. The tissue was washed with HBSS and then incubated
with trypsin inhibitor (type II-O, 10 mg/ml; Sigma) in HBSS
for 5 min. After an additional wash with HBSS, the tissue was
triturated in culture medium containing a-MEM (a-minimum
essential medium; Invitrogen) supplemented with 10% FBS
(fetal bovine serum; Hyclone), 20 mM glucose, 2 mM L-
glutamine, 1 mM sodium pyruvate, 14 mM sodium bicar-
bonate, 100 i.u./ml penicillin and 100 mg/ml streptomycin (pH
7.35). The resulting cell suspension was applied to culture
flasks and maintained in culture medium at 37˚Ci na5 %
CO2/95% air incubator. After 6–15 days, the cells were
submitted to a procedure for purification of astrocytes. At
that time, flasks were shaken on a horizontal orbital shaker at
260 rev./min for 1.5 h, and after changing the medium twice,
shaken again for 18 h. The cells that remained attached to the
bottom of the flask were then returned to the incubator to be
submitted to the transfection protocol (see below) or plated
on coverslips as follows. Prior to experiments, cells were
detached using trypsin [10000 BAEE (Na-benzoyl-L-arginine
ethyl ester hydrochloride) units/ml; Sigma–Aldrich] in HBSS
and then pelleted using centrifugation at 100 g for 10 min.
The resulting cell pellet was resuspended in complete medium
and plated on to glass coverslips (12 mm in diameter) pre-
coated with 1 mg/ml PEI (polyethyleneimine). The cells were
used in experiments after 2–10 days. This culture method
yields .99% astrocytes (Montana et al., 2004).
RT–PCR (reverse transcription-PCR)
Total RNA was extracted from purified cultures of astrocytes from
visual cortex and from whole-brain tissue of postnatal Sprague–
Dawley rats (0–2-days-old) using TRIzolH reagent (Invitrogen)
according to the manufacturer’s protocol. Total RNA (5 mg) was
used for reverse transcription using oligo(dT)12–18 and superscript
II reverse transcriptase (Invitrogen). Primers for CB1R (GenBankH
accession number U40395) amplification were 59-CCTTCAGGGG-
TAGTCCCTTC-39 and 59-ACATTGGGGCTGTCTTTACG-39 (producing
a 412 bp product).
Cell transfection
Transfection was performed using purified astrocytic culture
and a transfection reagent (TransIT-293; Mirus). At 1 h prior
to the transfection procedure, the astrocyte culture medium
was completely exchanged for fresh medium. The transfec-
tion agent was prepared by mixing a-MEM with no addi-
tives and TransIT-293 (36 ml/flask) reagent, followed by
vortex-mixing and incubating for 10 min at room temper-
ature (20–24˚C). At this time, plasmid DNA (6 mg/flask) was
added to the mixture and incubated for 10 min at room
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containing astrocytes grown on PEI-coated coverslips, which
were incubated for 1 h at 37˚C in a 5% CO2/95% air incu-
bator. Following incubation and wash-out of transfection
mixture, fresh complete medium was applied and cells were
returned to the incubator for 48–96 h, at which time they
were used for experiments. The following plasmids encoding
CB1R–GFP variant chimeras were used for the present study.
(i) The full-length CB1R with the enhanced GFP fused to the
C-terminus (CB1R–GFP). To generate C-terminally tagged
CB1R–GFP, rat CB1R (wild-type) was introduced into the
pEGFP-N1 plasmid (Clontech) between Hind3 and BamHI
cloning sites. The integrity of the construct was confirmed by
DNA sequencing. (ii) The full-length CB1R N-terminally
tagged with GFP or SEP and a signal sequence from human
growth hormone, in a pcDNA1 vector (GFP–CB1R and SEP–
CB1R respectively) (McDonald et al., 2007b). (iii) GFP–CB1R
truncated at its C-terminus and lacking 14 amino acids (GFP–
CB1RD14). The plasmid encoding the light chain of clathrin
tagged with DsRed (a red fluorescent protein; in the pDsRed-
N1 vector, Clontech) at the C-terminus, CLC–DsRed, was
kindly provided by Wolfhard Almers (Oregon Health and
Science University, Portland, OR, U.S.A.) (Merrifield et al.,
2002). Additional plasmids encoding fluorescent protein-
tagged cytoskeletal proteins were: (i) DsRed appended to the
C-terminus of the b5-tubulin, tubulin–DsRed, kindly provided
by Vincent Homburger (Institut de Genomique Fonctionnelle,
Montpellier, France) (Giau et al., 2005); and (ii) EYFP (enhanced
yellow fluorescent protein) fused to the N-terminus of the
human b-actin, EYFP–actin (Clontech).
Indirect immunocytochemistry
Cultured astrocytes were fixed with 4% (w/v) paraformalde-
hyde in PBS (pH57.4) for 30 min at room temperature. Cells
were then permeabilized using 0.25% Triton X-100 for 10
min. PBS supplemented with 10% goat serum was used to
block non-specific binding and cells were then incubated
with the primary antibody overnight at 4˚C. Rabbit polyclonal
antibodies against CB1R (2 mg/ml; Frontier Science) and
endobrevin/VAMP8 (1:250; Synaptic Systems), as well as the
monoclonal mouse antibody against synaptobrevin 2 (1:250
dilution; catalogue number 104 201, Synaptic Systems; please
note that this product has been replaced by the manufacturer
with catalogue number 104 211), were used. Following
washing, cells were incubated with TRITC (tetramethylrhoda-
mine isothiocyanate)-conjugated secondary antibody for 1 h.
Coverslips were then washed and mounted on to glass slides
with 1% n-propyl gallate for image acquisition.
Acutely isolated astrocytes
Cells were acutely isolated from visual cortices of 1- and 8-
day-old Sprague–Dawley rats using a modification (Montana
et al., 2004) of a previously described procedure (Zhou and
Kimelberg, 2000). Briefly, visual cortices isolated from rats
were subjected to papain treatment, followed by a trituration
as described for cell cultures. After trituration, cells were
applied to PEI-coated coverslips and allowed to adhere for 1
h. After washing, cells were fixed for immunocytochemistry.
We co-labelled acutely isolated astrocytes using the rabbit
antibody against CB1R and the mouse monoclonal antibody
against the astrocytic marker GFAP (glial fibrillary acidic
protein; 1:500; MP Biomedicals). Following overnight incuba-
tion with primary antibodies at 4˚C, washed cells were
incubated with FITC (fluorescein isothiocyanate) (for GFAP)-
and TRITC (for CB1R)-conjugated secondary antibodies for 1
h, washed and mounted on to glass slides with 1% n-propyl
gallate for image acquisition. Positive staining for CB1R and
GFAP was defined by the average pixel intensity across the
entire cell that was at least three S.D.s above background
fluorescence of cells in which CB1R/GFAP primary antibody
were omitted. All imaging data were background corrected by
subtracting the fluorescence emission from a coverslip region
containing no cells.
Imaging acquisition and processing
All experiments were performed at room temperature. For
live-cell imaging, cells were bathed in an external solution
that contained 140 mM NaCl, 5 mM KCl, 2 mM CaCl2,2m M
MgCl2, 5 mM glucose and 10 mM Hepes (pH57.4). We used
an inverted microscope (TE 300; Nikon) equipped with DIC
(differential interference contrast) and wide-field epifluores-
cence illumination. Visualization of indirect immunocyto-
chemistry was accomplished using a standard rhodamine/
TRITC filter set (excitation 535 nm/emission 610 nm) and a
fluorescein/FITC filter set (excitation 480 nm/emission 535
nm). A standard fluorescein/FITC filter set was used for
visualization of CB1R–GFP chimeras and EYFP–actin. A
standard Texas Red filter set (excitation 560 nm/emission
630 nm) was utilized for visualization of CLC–DsRed and
tubulin–DsRed. All filter sets were from Chroma Technology.
Images were captured through a 606 plan-Apo oil-
immersion objective [numerical aperture (NA), 1.4; Nikon]
using a CoolSNAP-HQ cooled CCD (charged-coupled device)
camera (Roper Scientific) driven by V++ imaging software
(Digital Optics) or MetaMorph Software (Molecular Devices).
For time-lapse image acquisition, a camera and an electronic
shutter (Vincent Associates) inserted into the excitation
pathway were controlled by imaging software. A Xenon arc
lamp (100 W) was used as a light source. All images shown in
the Figures and Movie 1 represent raw data with their pixel
intensities within the dynamic range (0–4095) of the camera
(CoolSNAP-HQ).
Ca
2+ imaging
Intracellular Ca
2+ levels in astrocytes were monitored using
the Ca
2+ indicator fluo-3 (Parpura et al., 1994; Parpura and
Haydon, 2000). Briefly, cells were loaded at room temperature
in external solution, containing fluo-3 AM (where AM is
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285acetoxymethyl ester, 10 mg/ml; Invitrogen) and Pluronic acid
(0.025%; Invitrogen) for 30 min. After washing in external
solution, the Ca
2+ indicator was permitted to de-esterify for
30 min at room temperature in external solution. Coverslips
containing dye-loaded cells were mounted on to a recording
chamber and imaged with a 206 plan-Fluor air objective (0.5
NA; Nikon) or a 606 plan-Apo oil-immersion objective. A
FITC filter set was used to visualize fluo-3 fluorescence. Data
were background subtracted using a fluorescence image
acquired in a region of coverslip without cells. Fluo-3
intensity changes of entire astrocytes were expressed as dF/
Fo (%), where dF represents the change of fluorescence after
cell stimulation and Fo represents the average fluorescence
(11 consecutive images) of the cell before stimulation. Stimu-
lation of astrocytes with the CB1R agonist WIN55,212-2 (1–
10 mM, 80 s) was achieved by its delivery via a puffer pipette
connected to the PicoSpritzer II pressure ejection system
(,70 kPa; Parker Haniffin). To assess the proper loading of
the Ca
2+ indicator, at the end of each experiment, cells were
incubated with the Ca
2+ ionophore 4-bromo-A23187 (10 mM,
3 min; Invitrogen). For further analysis we only considered
cells that displayed an increase in dF/Fo.100% after
incubation with the ionophore. Astrocytes were considered
responsive to the agonist if dF/Fo values were higher than
Fo+3S.D.s in at least two consecutive images.
CB1R tracking
Tracking of CB1R fluorescent puncta was performed using
MetaMorph software to acquire 60 frames, 1.5 frame/s time-
lapse series. The 200 highest-intensity puncta that were
between 4 and 70 pixels [the width of one pixel corresponds to
106 nm, imposed by the calculated Rayleigh’s transverse
resolution of 233nm (at 535nm emission)and by the Nyquist–
Shannon sampling theorem] in area were selected for
trafficking analysis. Only puncta found in thin regions of
astrocytes, peripheral to the perinuclear region, were tracked
to minimize the artefact associated with movement in the z-
axis as previously described (Potokar et al., 2005). Additionally,
the puncta that could not be tracked through the entire time-
lapse series, and those that intersected each other, were
discarded. Data were exported to Excel (Microsoft) and
algorithms were used to determine the instantaneous velocity,
maximal displacement (distance between the furthest two
points along a path of a punctum), total track length and
directionality index (ratio of maximal displacement to total
track length) for each punctum, as previously described
(Potokar et al., 2005). A custom-written Visual Basic routine
for Excel, referred to in the present study as a custom script,
was used to determine the movement of puncta relative to the
nucleus and plot the track of each punctum.
Pharmacological agents
Agents used in the assessment of intracellular Ca
2+ levels are
described above in the section on Ca
2+ imaging. All drugs
used in trafficking experiments to affect microtubule or actin
cytoskeleton dynamics were incubated with the cells prior to
imaging and were maintained in the external solution during
the imaging procedure. Colchicine (1 mM; 45 min) was used
for the disassembly of microtubules, whereas latrunculin B (5
mM; 45 min) was used to cause disassembly of F-actin. To
stabilize the microtubule cytoskeleton, paclitaxel (taxol) (1
mM; 1 h) was used, whereas jasplakinolide (1 mM; 1 h) was
used to stabilize F-actin. Bafilomycin A1 (5 mM; 30 min)
was incubated with cells to block V-ATPase (vacuolar-type
proton ATPase). All agents were from Sigma–Aldrich, except
latrunculin B and jasplakinolide (EMD Biosciences).
Statistical analysis
The effect of WIN55,212-2 on astrocytic intracellular Ca
2+
levels and changes in SEP–CB1R fluorescence due to
application of bafilomycin A1 or its vehicle (0.1% DMSO in
external solution) were assessed using a paired t test. A
Student’s t test was used to assess the difference in
instantaneous velocity of directional and non-directional
puncta, as well as to test any differences in instantaneous
velocity of directional puncta moving towards/away from the
nucleus. The comparison between trafficking measurements
using N- and C-terminally labelled CB1R and the effect of C-
terminal truncation on trafficking was also tested using a
Student’s t test. The effect of pharmacological agents
affecting the actin and microtubule cytoskeletons was tested
using one-way ANOVA followed by Fisher’s LSD (least
significant difference) test. The averages of each trafficking
measurement were made for all puncta of individual cells,
and the compiled cell averages for each experimental group
were tested. All results are expressed as means¡S.E.M. To
determine whether displacement angles were normally
distributed, a D’Agostino test was used. The dip test
(Hartigan, 1985; Hartigan and Hartigan, 1985) was done to
test for unimodality of displacement angle distributions using
the R 2.8.1 program with dip-test package installed (The R
Foundation for Statistical Computing).
RESULTS
Expression of native CB1R in visual cortex
astrocytes
Previous reports have questioned the presence of CB1R in
cultured astrocytes, whereas their expression in situ has been
more accepted [for a review see (Stella, 2004)]. Visual cortex
astrocytes have not been investigated for the presence of
CB1R up to this point. Thus, in the present study, we probed
purified visual cortex astrocyte cultures for the expression of
CB1R using a combination of immunocytochemistry, RT–PCR
analysis and Ca
2+ imaging (Figure 1). Indeed, mRNA for the
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(A) Localization of CB1R in cultured rat visual cortex astrocytes was identified by indirect immunocytochemistry using an antibody
against CB1R. Astrocytes display puncate staining throughout the entire cell body with some accumulation in the perinuclear region.
RT–PCR identified the presence of CB1R mRNA in cultured astrocytes (inset). The arrow indicates the 400 bp marker. RT–PCR primers
were designed to amplify a 412 bp fragment of the full-length CB1R transcript (middle lane, astrocytes; right-hand lane, whole
brain). (B) Indirect immunocytochemistry using antibodies against GFAP and CB1R on acutely isolated astrocytes from visual cortex
of P1 rats. Acutely isolated astrocytes that were identified by the presence of the specific marker GFAP (green, FITC) show typical
stellate morphology (DIC) and CB1R (red, TRITC) stain reminiscent of that seen in cultured astrocytes. (C) Stimulation of an astrocyte
with the CB1R agonist WIN55,212-2 (10 mM) causes an increase in the internal Ca
2+ elevations. The pseudocolour scale is a linear
representation of the fluorescence intensities ranging from 130 to 650 intensity units (i.u.). Times (in s) indicated on images
correspond to the time on the x-axis of the graph displaying a time-lapse of fluo-3 fluorescence, reporting on internal Ca
2+ levels.
(D) Changes in fluo-3 fluorescence are shown as dF/Fo (%) after background subtraction. The horizontal bar in the graph indicates
the application of WIN55,212-2.
CB1R trafficking in astrocytes
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287CB1R was detected in these cells (Figure 1A, inset).
Immunocytochemical labelling of CB1R with a CB1R antibody
raised against a previously characterized epitope (Katona
et al., 2006; Uchigashima et al., 2007) revealed that cultured
astrocytes have CB1Rs present throughout the cell, with some
accumulation in the perinuclear region, and show a punctate
staining pattern (Figure 1A). Since the expression of CB1R in
cultured astrocytes may result from gene expression changes
with culturing (Wilhelm et al., 2004), and not reflect
expression within the brain, we tested whether CB1R is
expressed in acutely isolated astrocytes from visual cortex by
immunocytochemistry. Astrocytes acutely isolated in this
manner have been shown to retain much of the gene
expression profile of those in situ (Kimelberg et al., 2000a,
2000b; Montana et al., 2004; Malarkey et al., 2008). Using
animals at postnatal days (P) 1 and 8, we found the
expression of CB1R in 52% (24 out of 46 tested) and 69% (9
out of 14 tested) of acutely isolated astrocytes respectively;
staining was similar to that found in cultured astrocytes
(Figure 1B). To test functionality of CB1R in cultured
astrocytes we used Ca
2+ imaging, since CB1R activation has
been demonstrated to cause Ca
2+ excitability in hippocampal
astrocytes (Navarrete and Araque, 2008). Consistent with that
finding, application of the CB1R agonist WIN55,212-2 (1–10
mM, 80 s) to astrocytes from visual cortex caused an increase
in intracellular Ca
2+ levels (Figures 1C and 1D) in all cells
tested (3 out of 3 at 1 mM; and 11 out of 11 at 10 mM; peak
response dF/Fo5111¡18%; paired t test, P,0.01). Taken
together these experiments demonstrate functional CB1R
expression within visual cortex astrocytes.
Mobility of CB1R–GFP in cultured astrocytes
In order to monitor the trafficking dynamics of CB1R we
transfected cultured astrocytes with a plasmid encoding
CB1R–GFP. Astrocytes expressing CB1R–GFP displayed bright
punctate fluorescence throughout the cell, with some
accumulation in the perinuclear region (Figure 2A and
Movie 1) reminiscent of native CB1R expression (Figure 1A).
Puncta 4–70 pixels large were tracked to investigate CB1R
mobility. The distribution of puncta sizes within the 4–70
pixel range for a single cell is shown in Figure 2(B). A similar
distribution pattern was observed with all cells. Examples of
paths taken for tracked puncta are shown in Figure 2(C),
coded in time by colour, and the position of the nucleus is
denoted by the large open circle. For the tracking of CB1R–
GFP puncta, we defined a greater than 1 mm maximum
displacement as directional mobility. A distance of 1 mm
approximates 1% of the diameter of a cultured astrocyte
(Potokar et al., 2005), and, within the time elapsed (40 s) in
our trafficking experiments, it is a distance that cannot be
attained by simple diffusion of an 80 nm particle in
Figure 2 Expression and trafficking of CB1R–GFP in astrocytes
(A) Astrocyte expressing full-length CB1R appended by GFP at its C-terminus (CB1R–GFP). The fluorescence pattern is similar to that
of native CB1R with puncta present throughout entire cell, with some accumulation within the perinuclear region of the cell. (B)
Distribution of CB1R–GFP puncta sizes within the size range selected for trafficking analysis for a single cell. For measurements of
CB1R–GFP trafficking, 200 puncta ranging from 4 to 70 pixels (one pixel is equal to 106 nm6106 nm) in area were selected based
on pixel intensity. Most of the puncta tracked fall within the 4–20 pixel area, whereas the incidence of puncta greater than 50 pixels
in area was minor. (C) Example paths of tracked CB1R–GFP puncta coded in time by colour. The relative position of the travelled path
of each punctum is indicated by the position of the nucleus (not drawn to scale). Both long-distance and short-range tracks can be
observed. The time-lapse sequence of the intracellular CB1R–GFP trafficking in astrocyte in (A) is shown in Movie 1.
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size of trafficking vesicles identified in astrocytes (Crippa
et al., 2006). The majority of CB1R–GFP puncta were found to
fall within the non-directional category, having maximum
displacement values less than 1 mm (Figure 3A). In comparing
non-directional to directional puncta, it was found that non-
directional puncta display instantaneous velocities signifi-
cantly lower than that of puncta within the directional
category (Figure 3B; Student’s t test, P,0.01). By plotting
MSD (mean square displacement) as a function of time, a
linear relationship was found for non-directional puncta
(Figure 3C) which can be fitted (r
25 0.996) by eqn (1):
MSD mm2 
~0:064 mm2=s|time s ðÞ z0:0114 mm2 ð1Þ
This is consistent with the movement of non-directional
puncta being governed by simple diffusion, where the slope
in the above equation can be used to calculate an apparent
diffusion coefficient (D) of 1.6610
210 cm
2/s using eqn (2):
MSD~4Dt ð2Þ
[For a detailed procedure see (Potokar et al., 2005).] The
movement of directional puncta appears to be governed by a
more complex mechanism(s) than simple diffusion and it can
be best fitted by a power relationship (r
25 0.999), followed
by a dual reciprocal function (r
25 0.980).
Role of distal C-terminus in CB1R trafficking
dynamics
The C-terminus of transmembrane proteins such as GPCRs
often has an important role in the trafficking of the receptor.
The distal C-terminus of CB1R has previously been implicated
in endocytosis of the receptor (Hsieh et al., 1999) and may
also bind CRIP (cannabinoid receptor interacting protein) 1a
(Niehaus et al., 2007). To test whether the C-terminus has a
role in the trafficking dynamics of CB1R, an N-terminally GFP-
tagged CB1R with a C-terminal 14-amino-acid truncation
(D14aa) was expressed in cultured astrocytes. We determined
instantaneous velocity, maximal displacement, the fraction of
directional puncta (having a greater than 1 mm maximal
displacement), total track length and directionality index of
GFP-tagged CB1R puncta. The directionality index was used to
determine the extent of rectilinear movement. Comparing
measurements of trafficking dynamics for cells expressing
GFP–CB1RD14aa to the control/full-length GFP–CB1R we
found that the absence of the C-terminal 14 amino acids
resulted in a significant reduction in a subset of trafficking
parameters (instantaneous velocity and total track length;
Student’s t test, P,0.05) (Figures 4A and 4D; column 1
compared with column 2). When we compared trafficking
dynamics for cells expressing the N-terminally tagged GFP–
CB1R to C-terminally tagged CB1R–GFP, however, we found
that tagging CB1R at its C-terminus had no significant effect
on any parameter tested (Student’s t test; P50.08–0.97 for
various parameters; Figures 4A–4E; column 2 compared with
column 3). Taken together these findings may reflect a specific
function of the distal part of the CB1R C-terminus in receptor
trafficking, but will require further studies of regulatory
protein interactions within this region to support this idea.
Role of actin and microtubule cytoskeletons in
CB1R–GFP trafficking
We investigated the role of cytoskeletal elements on the
trafficking of CB1R with the use of pharmacological agents
Figure 3 Mobility of CB1R–GFP puncta in astrocytes
(A) CB1R–GFP puncta were tracked during a 60 frame time-lapse series (40 s;
Movie 1) and categorized by their maximal displacement, with non-
directional puncta having maximal displacement less than 1 mm (solid bars)
and directional greater than 1 mm (open bars). The histogram shows the
relative frequency of maximal displacement values, expressed as a percentage
for all puncta (n51650) within the cell analysed (n514). (B) Non-directional
CB1R–GFP puncta (solid bar) display a significantly slower instantaneous
velocity compared with the directional group (open bar) (Student’s t test,
**P,0.01). Bars represent mean instantaneous velocity¡S.E.M. Values in
parentheses indicate the number of cells; total number of puncta. (C) Graph
showing the average MSD¡S.E.M. as a function of time for all tracked
CB1R–GFP puncta within the non-directional (&) and directional (%)
categories. Examples of single puncta mobility tracks for each category are
shown next to the graph traces and are colour-coded for time as described in
Figure 2(C); the total track length is 4.7 mm and 0.84 mm for directional and
non-directional puncta respectively.
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289Figure 4 Distal C-terminal truncation of CB1R affects intracellular trafficking of this receptor, which utilizes microtubules and actin
filaments for its traffic
(A–E) Trafficking dynamics for cells expressing N-terminally tagged GFP–CB1R (column 2) display similar characteristics (no
statistical difference) as C-terminally tagged CB1R–GFP (column 3). Truncation of GFP–CB1R at its C-terminal 14 amino acids
(D14aa) reduces the instantaneous (Instant) velocity (A) and total track length (D) when compared with the control cells expressing
the full-length GFP–CB1R (compare columns 1 and 2; Student’s t test, *P,0.05). (A) Instantaneous velocity analysis of C-terminally
tagged CB1R–GFP shows a decrease from control (column 3) when cells are treated with jasplakinolide (column 7). (B) Average
maximal displacement was reduced significantly compared with control when cells were treated with colchicine and jasplakinolide
(compare columns 3, 4 and 7). (C) The fraction of directional puncta was reduced when cells were treated with colchicine and
jasplakinolide (compare columns 3, 4 and 7). (D) The average total length of tracks travelled by puncta was shorter for jasplakinolide-
treated cells (compare columns 3 and 7). (E) The directionality index was reduced compared with control when cells were treated
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leton dynamics. The effect of cytoskeleton-disrupting agents,
colchicine for destabilization of microtubule and latrun-
culin B for destabilization of actin filaments, was verified
using astrocytes expressing tubulin–DsRed or EYFP–actin
respectively. We found that the fluorescence intensities of
microtubule tracks, as visualized by tubulin–DsRed, and actin
filaments, as visualized by EYFP–actin, were reduced after
treatment with these cytoskeleton-disrupting agents (data
not shown). To assess the role of cytoskeletal elements in
CB1R trafficking, astrocytes expressing CB1R–GFP were
subjected to incubation with pharmacological agents prior
to acquiring time-lapse series. Trafficking measurements for
drug-treated cells were compared with control untreated
cells, to determine the dependence on microtubules or actin
filaments in CB1R–GFP trafficking (Figure 4; columns 3–7).
All parameters except instantaneous velocity and total track
length were decreased when astrocytes were treated with
colchicine to depolymerize microtubules (Figures 4B, 4C and
4E; column 3 compared with column 4; one-way ANOVA
followed by Fisher’s LSD test, P,0.01). The effect of
colchicine on reducing the directionality index implicates
microtubule-based transport in long-distance, straight-line
movement of CB1R–GFP. When microtubules were stabilized
using paclitaxel, no difference from control was observed, but
a significant increase in all parameters was seen when
compared with colchicine-treated cells (Figures 4A–4E;
column 4 compared with column 5, one-way ANOVA
followed by Fisher’s LSD test, P,0.05 or P,0.01 for various
parameters). Actin depolymerization with latrunculin B had
no significant effect on trafficking parameters from controls
(Figure 4; column 3 compared with column 6), but it showed
significantly greater trafficking parameters, with the excep-
tion of directionality index, when compared with astrocytes
treated with jasplakinolide to cause actin filament stabiliza-
tion (Figures 4A–4D; column 6 compared with column 7;
one-way ANOVA followed by Fisher’s LSD test, P,0.05 or
P,0.01 for various parameters). Astrocytes treated with
jasplakinolide resulted in a significant decrease in all
measurements, with the exception of directionality index,
when compared with control (Figures 4A–4D; column 3
compared with column 7, one-way ANOVA followed by
Fisher’s LSD test, P,0.01), indicating that an interaction with
actin filaments may act to slow CB1R–GFP puncta velocity.
Taken together, these data show that both microtubules and
actin filaments play a role in CB1R–GFP trafficking in
astrocytes.
Preferential radial trafficking of directional
CB1R–GFP puncta along microtubules
Since pharmacological experiments suggest that much of the
directional trafficking of CB1R–GFP relies on microtubule-
based mechanisms, we attempted to verify movement along
microtubules visually. When CB1R–GFP was co-expressed in
astrocytes with tubulin–DsRed, which labelled microtubules
with red fluorescent protein, CB1R–GFP puncta could be seen
travelling along the track of microtubules (data not shown).
The dynamics of puncta seen moving along microtubules
travelled at higher rates, consistent with microtubule-based
trafficking, further suggesting microtubule-based mechan-
isms for the trafficking. Therefore a strategy was devised in
an attempt to find any pattern or preferential movement of
directional puncta. Since across cell types microtubules
polymerize in a radial manner from the microtubule-
organizing centre to the cell periphery, and our results
suggest that directional CB1R trafficking relies on micro-
tubules, we investigated whether there was a preference for
radially patterned movement. A custom script was written to
plot the path of each directional punctum (maximal
displacement values greater than 1 mm) relative to the
nucleus in which trajectory displacement angles away from
the nucleus were assigned positive angles ranging from 0 to
90˚ with increasing angles more tangential, whereas those
towards the nucleus were assigned by the same convention
with negative angles (Figure 5A). We first assessed whether
directional puncta moving towards or away from the nucleus
showed differences in trafficking velocity. No difference in
the instantaneous velocity was found between structures
trafficking towards or away from the nucleus (Figure 5B;
n513, Student’s t test, P50.5). To determine whether
particular directions of active transport predominate, analysis
was conducted using histograms of trajectory displacement
angles for directional puncta (n5557 from 13 cells). Angles
near 0˚ were found to predominate with a significantly
unimodal distribution [dip test, D(F557)50.0106, P,0.05],
even though the normality of distribution was rejected
(D’Agostino Test, D953772.9; P,0.01), indicating that the
majority of CB1R–GFP puncta were trafficking more radially
directly towards or away from the nucleus (Figure 5C).
Since microtubules are arranged in a radial pattern centred
at the microtubule-organizing centre near the cell nucleus, it
was suspected that transport along microtubules might
underlie the observed preferential trafficking of directional
CB1R–GFP. To test this we compared colchicine- and
latrunculin-B-treated cells with untreated control cells
with colchicine (compare columns 3 and 4). Treatments with opposing actions on microtubules, disruption by colchicine and
stabilization by paclitaxel, show a significant difference in all measured parameters (compare columns 4 and 5). Similarly, treatments
with opposing actions on actin meshwork, disruption by latrunculin B and stabilization by jasplakinolide, show a significant
difference in all measured parameters (A–D; compare columns 6 and 7), with the exception of the directionality index (E). The effect
of pharmacological agents affecting cytoskeletal elements on C-terminally labelled CB1R–GFP trafficking was statistically tested
using one-way ANOVA followed by a post-hoc Fisher’s LSD test; *P,0.05 and **P,0.01 respectively. All bars, numbered by column to
aid comparison, represent means¡S.E.M. of individual cell averages for tracked puncta. Values in parentheses indicate number of
cells; total number of puncta.
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291expressing CB1R–GFP. Depolymerization of microtubules with
colchicine abolished the unimodal pattern [dip test,
D(F133)50.0319,P.0.05],whereasthenormalityofdistribution
remained rejected (D’Agostino Test, D95441.3; P,0.01),
confirming that radial traffic of directional CB1R–GFP puncta
occured along microtubules. An apparent bimodal distribution
arises with the angle trajectories near 220˚and 50˚,c o n s i s t e n t
with the remaining movement along actin filaments (n5133
from seven cells; Figure 5D). Treatment with latrunculin B to
disrupt actin filaments accentuated the near 0˚ angles mode
with a reduction in the frequency of larger angles (Figure 5E),
indicating actin filament function in the trafficking of CB1R–
GFP along tracks tangential to the nucleus. The distribution was
not found to be unimodal [dip test, D(F202)50.0213, P.0.05],
but it was found normal (D’Agostino test, D95809.7, P.0.05;
n5202 from five cells). Taken together, it appears that
the disruption of microtubules leads to the reduction of the
preferential radial traffic based on the analysis of angle
trajectories of directional CB1R–GFP puncta, which is consist-
ent with the decrease of directionality index in colchicine-
treated astrocytes (Figure 4E).
Intracellular localization of CB1R in astrocytes
We used astrocytes expressing superecliptic pHluorin-tagged
CB1R (SEP–CB1R; McDonald et al., 2007b), rather than
GFP–CB1R, to initiate investigations into the subcellular
localization of CB1R in astrocytes. Although GFP is pH-
sensitive (Patterson et al., 1997), SEP has an enhanced pH
sensitivity. Its fluorescence is nearly completely quenched at
pH levels below 6 and quenching is relieved at higher pH
(Miesenbock et al., 1998). Because the SEP is located on the
Figure 5 Preferential radial trafficking of directional CB1R–GFP
(A) Diagram shows the convention used for defining displacement angles (/), ranging from 290˚to 90˚, from the path (dotted line) of
theindividualdirectionalCB1R–GFPpuncta.Angle values approach 0˚astrajectoriesbecomemoreradial,directlytowardsor away from
the nucleus of the cell (N), whereas more tangential trajectories associate with angle values approaching ¡90˚.( B) The instantaneous
(Instant) velocity of directional CB1R–GFP puncta trafficking away (+ Angle) from the nucleus was no different from that observed for
puncta travelling towards (2 Angle) the nucleus (n513 cells). (C–E) Charts show frequency histograms of displacement angles for
control (C), colchicine-treated (D) and latrunculin B-treated (E) cells . (C) Histogram of displacement angles for control cells shows
unimodal distribution (n5557 puncta; dip-test, P,0.05) with the mode near 0˚identifying the preferential mode of directional CB1R–
GFP trafficking to be radial, towards and away from the nucleus, whereas a substantial amount of trafficking occurs tangential to the
nucleus. (D) When cells were treated with colchicine, the preference for radial trafficking is abolished (n5133 puncta), with display of
anapparentbimodaldistribution. (E)Near0˚anglespredominatewithdisplacementanglesshowingnormal(n5202puncta;D’Agostino
Test, P.0.05), albeit not unimodal, distribution, when astrocytes were treated with latrunculin B.
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(pH,6) lumen of vesicular structures or extracellular fluid
(pH57.4) when on the plasma membrane, we can determine
whether CB1R resides in acidic compartments. To this end we
exposed cells expressing SEP–CB1R to bafilomycin A1, a
blocker of V-ATPase, to cause de-acidification of low pH
compartments (Figures 6A and 6B). With exposure to
bafilomycin A1, cells expressing SEP–CB1R showed an
increase in maximal fluorescence (dF/Fo5118¡30%, n54;
paired t test, P,0.05), which became highly punctate.
However, in sham-treatment of cells where only the vehicle
was applied, cells expressing SEP–CB1R did not show
significant changes in maximal fluorescence (dF/
Fo5222¡8%, n55; paired t test, P50.14). These results
indicate that a population of CB1R resides in low pH
intracellular compartments.
Since various cellular organelles have an acidic luminal pH
established and maintained by V-ATPase, we additionally co-
labelled astrocytes expressing CB1R–GFP with markers for
various intracellular compartments to further study the
Figure 6 Intracellular CB1R localization in astrocytes
(A and B) The presence of SEP–CB1R in low-pH intracellular structures. (A) Astrocyte expressing SEP–CB1R at rest. (B) After
incubation with bafilomycin A1 to block V-ATPase, SEP–CB1R fluorescence intensity increases displaying more prominently punctate
fluorescence indicating that a population of SEP–CB1R exists within acidic compartments. The pseudocolour scale is a linear
representation of the fluorescence intensities ranging from 100 to 1200 intensity units (i.u.). (C–E) Intracellular CB1R–GFP localizes
in endosomes. (C) CB1R–GFP (green, middle panel)-expressing astrocytes immunolabelled for endobrevin (VAMP8) (red, left-hand
panel), an endosomal marker. Arrowheads mark some instances of co-localization of CB1R–GFP and endogenous VAMP8 (overlay,
right-hand panel). (D) Co-expressed CLC–DsRed (red, left-hand panel), labelling early endocytic structures, and CB1R–GFP (green,
middle panel) show very little co-localization (overlay, right-hand panel; arrowhead). (E) CB1R–GFP (green, middle panel)-expressing
astrocytes immunolabelled for the exocytotic vesicle marker synaptobrevin 2 (Sb2) (red, left-hand panel). Subcellular localization
of CB1R–GFP and Sb2 immunoreactivity show some overlap (overlay, right-hand panel; arrowheads) within the perinuclear region of
the cell, whereas co-localization was not apparent at the periphery of the cell.
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293subcellular localization of this receptor. CB1R has been shown
to be primarily endocytic in origin (Leterrier et al., 2004), and
to undergo endocytosis through caveolae and clathrin-
dependent pathways (Keren and Sarne, 2003). To test whether
astrocytic CB1R is found within the endocytic pathway, we
examined the co-localization of CB1R with endobrevin
(VAMP8) (Figure 6C) and with clathrin (Figure 6D). Astro-
cytes expressing CB1R–GFP were either immunolabelled using
an antibody against VAMP8 or they were co-transfected to co-
express clathrin light-chain–DsRed (CLC–DsRed). CB1R–GFP
mainly co-localized with VAMP8 immunoreactivity, whereas
there was very little co-localization with CLC–DsRed. These
results indicate the predominant localization of CB1R within
endosomes containing VAMP8 over early endocytic structures
containing clathrin. Moreover, astrocytes expressing CB1R–
GFP were also immunolabelled using an antibody against
the exocytotic protein synaptobrevin 2 (Figure 6E). CB1R–GFP
co-localized with some of the synaptobrevin 2, which was
evidentintheperinuclearregionofthecell,whereasperipheral
co-localization was not detected.
DISCUSSION
The presence of CB1R in cultured astrocytes has been found
to vary between astrocyte cultures originating from different
animal strains and between cultures originating from
different brain areas (Stella, 2004). This may be explained
by the emerging picture that astrocytes are a diverse
population of cells that may have different gene-expression
profiles dependent upon the particular region of the CNS
(central nervous system) in which they reside. Using cultured
rat visual cortex astrocytes we found CB1R to be expressed at
the transcript and protein levels; these receptors are
functional since their activation with a CB1R agonist leads
to intracellular Ca
2+ excitability. In addition, we showed that
CB1R is expressed in acutely isolated astrocytes of rat visual
cortex, indicating that the expression of CB1R occurs in
these astrocytes within the brain. Whether cultures of visual
cortex astrocytes may therefore provide a suitable system to
investigate the function of astrocytic CB1R as a distinct
function of CB1R in astrocytes in vivo remains to be
elucidated. Towards that end, there has been a recent
demonstration that CB1R plays a role in neuron–astrocyte
signalling in hippocampal slices (Navarrete and Araque,
2008).
The characteristics of protein trafficking in astrocytes have
recently begun to be investigated, with particular emphasis
on trafficking of proteins in the exocytotic pathway. The
present study of CB1R trafficking in astrocytes constitutes
the first investigation of protein trafficking dynamics of a
plasma membrane expressed receptor in astrocytes. Under
resting conditions, a large proportion of recombinant CB1R is
constitutively endocytosed and present within intracellular
vesicles in neurons (McDonald et al., 2007a) or HEK (human
embryonic kidney)-293 cells (Leterrier et al., 2004). Since we
observed a prominent perinuclear stain for native (Figures 1A
and 1B) and exogenous (Figures 2A, and 6C–6E) CB1R, it is
possible that this represents some of the recycled CB1R, in
addition to its synthesis, suggesting that in visual cortex
astrocytes the receptor could undergo marked constitutive
endocytosis. We found, similarly to ANP (Potokar et al., 2005)
and synaptobrevin 2 (Crippa et al., 2006), that the majority of
CB1R puncta are immobile, as defined by maximum
displacement values less than 1 mm. These results are in
contrast with the finding that post-Golgi PN-1 vesicles are
nearly all mobile (Giau et al., 2005). The fact that these
authors selectively analysed vesicles that were newly budded
from the Golgi network may account for some of the
differences in the findings. To determine the underlying
mechanism for movement of non-directional CB1R–GFP
puncta, we examined the relationship between MSD and
time. A linear relationship was found for non-directional
puncta, indicating that diffusion may govern movement
of puncta within this class. An apparent diffusion coefficient
of 1.6610
210 cm
2/s was calculated from the linear fit of
MSD against time for non-directional puncta. The apparent
diffusion coefficient for CB1R–GFP is less than that
determined for ANP (6.8610
210 cm
2/s) in astrocytes
(Potokar et al., 2005). Overall it was observed that CB1R–
GFP puncta trafficked at an instantaneous velocity of 0.11
mm/s, with directional puncta trafficking at an instantaneous
velocity of 0.15 mm/s and non-directional puncta with an
instantaneous velocity of 0.07 mm/s. In comparison with
published data of velocities observed in astrocytes, CB1R–
GFP-positive structures move at a slower rate. Velocities of
0.65 mm/s and 0.4 mm/s were found for synaptobrevin 2
(Crippa et al., 2006) and ANP (Potokar et al., 2005)
respectively.
In general, movement at higher velocities, such as observed
with directional CB1R puncta, is driven by motor proteins
using microtubules or F-actin as tracks for directed
movement (Evans and Bridgman, 1995; Goldstein and Yang,
2000). We therefore sought to determine the extent to which
microtubules and/or actin filaments are used for the
movement of CB1R. Through pharmacological disruption of
these cytoskeletal elements we found CB1R–GFP trafficking
to be dependent upon microtubules. In addition, an
interaction was identified between CB1R–GFP puncta and
actin filaments, as stabilization of actin filaments resulted in
an overall decrease in CB1R–GFP mobility. Some evidence
exists for actin-dependent trafficking within astrocytes
(Stachelek et al., 2001); the hormone-activated trafficking
of the enzyme type II deiodinase (D2) from the cell periphery
to recycling endosomes is dependent upon myosin 5a, an
actin-based motor protein. Although we found CB1R within
the endocytic pathway in astrocytes and could therefore be
trafficked to endosomes from the cell periphery similar to D2,
our results suggest that this is not the case. Depolymerization
of actin filaments resulted in no significant decrement of
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transport were used for a component of CB1R trafficking,
using perhaps myosin 5a, then depolymerizing actin filaments
may reduce trafficking measures. Although it does not appear
that long-range movement of CB1R occurs via actin-based
mechanisms as observed with D2, since depolymerizing
microtubules does not completely abolish active transport
and since opposing pharmacological treatments to disrupt or
stabilize actin caused significant differences in trafficking
parameters, some actin-based trafficking of CB1R may occur.
Cortical F-actin has been shown to regulate mobility of
secretory granules and clathrin-mediated endocytosis, and, as
such, it may be that the interaction of CB1R–GFP and actin is
short-lived and occurs at the cell periphery (Lang et al., 2000;
Merrifield et al., 2002). As would be expected by the
arrangement of microtubules, we found directional CB1R–
GFP puncta to preferentially traffic in a radial pattern from/
to the nucleus. Cargo vesicles carrying CB1R–GFP to the cell
periphery may, to some extent, underlie the radial traffic.
Since it was found that a subpopulation of CB1R–GFP reside
in endosomes, and long-range tracks toward the nucleus
were observed, endosomal traffic may also constitute a
portion of the radial trafficking of CB1R–GFP. Indeed there is
evidence in the literature that could support a role for
microtubules in CB1R endosomal trafficking. Leterrier et al.
(2004) observed long-range movement of CB1R-positive
endosomes. It should be noted that astrocytes express
kinesins (Crippa et al., 2006). Energetically, transport of
CB1R–GFP in astrocytes is costly, as microtubule-based
motors and myosins expend one ATP molecule at each
individual step. With a range of step-size for these motors
from 8 to 30 nm (Howard et al., 1989; Rock et al., 2007), the
ATP expense of the transport of a single CB1R–GFP punctum,
at average instantaneous velocity, is between 5 and 19 ATP
molecules used every second.
Classically, the relative amount of receptors expressed at
the cell surface, which was beyond the scope of the present
study, will shape the response to extrinsic signalling
molecules. However, vesicular (intracellular) CB1Rs can still
engage cell signalling (Gomes et al., 2009), which may be
activated by lipophilic (membrane-permeant) cannabinoid
ligands or via innate constitutive activity. Astrocytes play an
active role in cell-to-cell communication in the brain, in part,
reliant on neuroligand receptors. Investigations into the
trafficking of receptors within astrocytes will provide
important data as to astrocyte function. CB1R trafficking
may be of particular interest within astrocytes; it was found
that CB1R preferentially localizes to the astrocytic end-foot
(Rodriguez et al., 2001). Preferential localization is governed
by distinct sorting signals and pathways that effectively
target proteins to their respective domain. Such signals and
pathways governing targeting in astrocytes await identifica-
tion. Astrocyte end-feet couple to each other along the
vasculature through gap junctions formed by connexin 43
(Simard et al., 2003). Interestingly cannabinoid ligands have
been demonstrated to block gap-junctional coupling in
astrocytes, although CB1R was not directly implicated in this
finding (Venance et al., 1995). Local signalling occurring at
astrocyte end-feet can modulate cerebrovascular blood flow,
and can spread via gap junctions along the vasculature
(Simard et al., 2003; Mulligan and MacVicar, 2004). As the
constitutive trafficking of CB1R to and from the plasma
membrane is an energetically costly endeavour for astrocytes,
this process is likely to play a role in shaping the cellular
response to endogenous cannabinoid ligands or constitutive
signalling activity. Thus future studies might investigate the
involvement of cannabinoid signalling at the astrocyte end-
foot, and the role of constitutive CB1R trafficking in this.
ACKNOWLEDGEMENTS
We dedicate this work to the late Glenn I. Hatton, whose
energy and creativity inspired new views of astrocyte–
neuronal interactions.
FUNDING
This work was supported by the National Institute of Mental
Health [grant number MH 069791 (to V.P.)]; the National
Science Foundation [grant number CBET 0943343 (to V.P.)];
TENOVUSScotland(toA.J.I.);andtheAnonymousTrust(toA.J.I.).
REFERENCES
Aoki C, Joh TH, Pickel VM (1987) Ultrastructural localization of b-adrenergic
receptor-like immunoreactivity in the cortex and neostriatum of rat
brain. Brain Res 437:264–282.
Coutts AA, Anavi-Goffer S, Ross RA, MacEwan DJ, Mackie K, Pertwee RG,
Irving AJ (2001) Agonist-induced internalization and trafficking of
cannabinoid CB1 receptors in hippocampal neurons. J Neurosci 21:2425–
2433.
Crippa D, Schenk U, Francolini M, Rosa P, Verderio C, Zonta M, Pozzan T,
Matteoli M, Carmignoto G (2006) Synaptobrevin 2-expressing vesicles in
rat astrocytes: insights into molecular characterization, dynamics and
exocytosis. J Physiol 570:567–582.
Evans LL, Bridgman PC (1995) Particles move along actin filament bundles in
nerve growth cones. Proc Natl Acad Sci USA 92:10954–10958.
Giau R, Carrette J, Bockaert J, Homburger V (2005) Constitutive secretion of
protease nexin-1 by glial cells and its regulation by G-protein-coupled
receptors. J Neurosci 25:8995–9004.
Goldstein LS, Yang Z (2000) Microtubule-based transport systems in neurons:
the roles of kinesins and dyneins. Annu Rev Neurosci 23:39–71.
Gomes I, Grushko JS, Golebiewska U, Hoogendoorn S, Gupta A, Heimann AS,
Ferro ES, Scarlata S, Fricker LD, Devi LA (2009) Novel endogenous peptide
agonists of cannabinoid receptors. FASEB J 23:3020–3029.
Hartigan JA, Hartigan PM (1985) The dip test of unimodality. Anal Stat
13:70–84.
Hartigan PM (1985) Computation of the dip statistic to test for unimodality.
Appl Stat 34:320–325.
Howard J, Hudspeth AJ, Vale RD (1989) Movement of microtubules by single
kinesin molecules. Nature 342:154–158.
Hsieh C, Brown S, Derleth C, Mackie K (1999) Internalization and recycling of
the CB1 cannabinoid receptor. J Neurochem 73:493–501.
Katona I, Urban GM, Wallace M, Ledent C, Jung KM, Piomelli D, Mackie K,
Freund TF (2006) Molecular composition of the endocannabinoid system
at glutamatergic synapses. J Neurosci 26:5628–5637.
Keren O, Sarne Y (2003) Multiple mechanisms of CB1 cannabinoid receptors
regulation. Brain Res 980:197–205.
Kimelberg HK, Cai Z, Schools G, Zhou M (2000a) Acutely isolated astrocytes
as models to probe astrocyte functions. Neurochem Int 36:359–367.
CB1R trafficking in astrocytes
E 2009 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.
295Kimelberg HK, Schools GP, Cai Z, Zhou M (2000b) Freshly isolated astrocyte
(FIA) preparations: a useful single cell system for studying astrocyte
properties. J Neurosci Res 61:577–587.
Lang T, Wacker I, Wunderlich I, Rohrbach A, Giese G, Soldati T, Almers W
(2000) Role of actin cortex in the subplasmalemmal transport of
secretory granules in PC-12 cells. Biophys J 78:2863–2877.
Leterrier C, Bonnard D, Carrel D, Rossier J, Lenkei Z (2004) Constitutive
endocytic cycle of the CB1 cannabinoid receptor. J Biol Chem
279:36013–36021.
Luby-Phelps K (2000) Cytoarchitecture and physical properties of cytoplasm:
volume, viscosity, diffusion, intracellular surface area. Int Rev Cytol
192:189–221.
Malarkey EB, Ni Y, Parpura V (2008) Ca
2+ entry through TRPC1 channels
contributes to intracellular Ca
2+ dynamics and consequent glutamate
release from rat astrocytes. Glia 56:821–835.
McDonald NA, Henstridge CM, Connolly CN, Irving AJ (2007a) An essential
role for constitutive endocytosis, but not activity, in the axonal targeting
of the CB1 cannabinoid receptor. Mol Pharmacol 71:976–984.
McDonald NA, Henstridge CM, Connolly CN, Irving AJ (2007b) Generation and
functional characterization of fluorescent, N-terminally tagged CB1
receptor chimeras for live-cell imaging. Mol Cell Neurosci 35:237–248.
Merrifield CJ, Feldman ME, Wan L, Almers W (2002) Imaging actin and
dynamin recruitment during invagination of single clathrin-coated pits.
Nat Cell Biol 4:691–698.
Miesenbock G, De Angelis DA, Rothman JE (1998) Visualizing secretion and
synaptic transmission with pH-sensitive green fluorescent proteins.
Nature 394:192–195.
Montana V, Ni Y, Sunjara V, Hua X, Parpura V (2004) Vesicular glutamate
transporter-dependent glutamate release from astrocytes. J Neurosci
24:2633–2642.
Mulligan SJ, MacVicar BA (2004) Calcium transients in astrocyte endfeet
cause cerebrovascular constrictions. Nature 431:195–199.
Navarrete M, Araque A (2008) Endocannabinoids mediate neuron-astrocyte
communication. Neuron 57:883–893.
Niehaus JL, Liu Y, Wallis KT, Egertova M, Bhartur SG, Mukhopadhyay S, Shi S,
He H, Selley DE, Howlett AC, Elphick MR, Lewis DL (2007) CB1
cannabinoid receptor activity is modulated by the cannabinoid receptor
interacting protein CRIP 1a. Mol Pharmacol 72:1557–1566.
Parpura V, Haydon PG (2000) Physiological astrocytic calcium levels stimulate
glutamate release to modulate adjacent neurons. Proc Natl Acad Sci USA
97:8629–8634.
Parpura V, Basarsky TA, Liu F, Jeftinija K, Jeftinija S, Haydon PG (1994)
Glutamate-mediated astrocyte-neuron signalling. Nature 369:744–747.
Patterson GH, Knobel SM, Sharif WD, Kain SR, Piston DW (1997) Use of the
green fluorescent protein and its mutants in quantitative fluorescence
microscopy. Biophys J 73:2782–2790.
Potokar M, Kreft M, Pangrsic T, Zorec R (2005) Vesicle mobility studied in
cultured astrocytes. Biochem Biophys Res Commun 329:678–683.
Potokar M, Kreft M, Li L, Daniel Andersson J, Pangrsic T, Chowdhury HH,
Pekny M, Zorec R (2007) Cytoskeleton and vesicle mobility in astrocytes.
Traffic 8:12–20.
Rock RS, Rice SE, Wels AL, Purcell TS, Spudich JA, Sweeny HL (2007) Myosin
VI is a processive motor with a large step size. Proc Natl Acad Sci USA
98:13655–13659.
Rodriguez JJ, Mackie K, Pickel VM (2001) Ultrastructural localization of the
CB1 cannabinoid receptor in mu-opioid receptor patches of the rat
caudate putamen nucleus. J Neurosci 21:823–833.
Shumay E, Gavi S, Wang HY, Malbon CC (2004) Trafficking of b2-adrenergic
receptors: insulin and b-agonists regulate internalization by distinct
cytoskeletal pathways. J Cell Sci 117:593–600.
Simard M, Arcuino G, Takano T, Liu QS, Nedergaard M (2003) Signaling at the
gliovascular interface. J Neurosci 23:9254–9262.
Stachelek SJ, Tuft RA, Lifschitz LM, Leonard DM, Farwell AP, Leonard JL (2001)
Real-time visualization of processive myosin 5a-mediated vesicle
movement in living astrocytes. J Biol Chem 276:35652–35659.
Stella N (2004) Cannabinoid signaling in glial cells. Glia 48:267–277.
Uchigashima M, Narushima M, Fukaya M, Katona I, Kano M, Watanabe M
(2007) Subcellular arrangement of molecules for 2-arachidonoyl-glycerol-
mediated retrograde signaling and its physiological contribution to
synaptic modulation in the striatum. J Neurosci 27:3663–3676.
Venance L, Piomelli D, Glowinski J, Giaume C (1995) Inhibition by anandamide
of gap junctions and intercellular calcium signalling in striatal astrocytes.
Nature 376:590–594.
Verkhratsky A (2006) Glial calcium signaling in physiology and patho-
physiology. Acta Pharmacol Sin 27:773–780.
Wilhelm A, Volknandt W, Langer D, Nolte C, Kettenmann H, Zimmermann H
(2004) Localization of SNARE proteins and secretory organelle proteins in
astrocytes in vitro and in situ. Neurosci Res 48:249–257.
Zhou M, Kimelberg HK (2000) Freshly isolated astrocytes from rat
hippocampus show two distinct current patterns and different [K(+)](o)
uptake capabilities. J Neurophysiol 84:2746–2757.
Received 31 July 2009/6 November 2009; accepted 11 November 2009
Published as Immediate Publication 11 November 2009, doi 10.1042/AN20090040
KD Osborne and others
296 E 2009 The Author(s) This is an Open Access article distributed under the terms of the Creative Commons Attribution Non-Commercial Licence (http://creativecommons.org/licenses/by-nc/2.5/)
which permits unrestricted non-commerical use, distribution and reproduction in any medium, provided the original work is properly cited.